Additional time enables LAVA Therapeutics to address potential liabilities and confirm net cash to be delivered to Shareholders. LAVA Therapeutics and XOMA Royalty anticipate closing the announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback